Hims & Hers Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 82W.F | PBH | MEGA.BK | THEMISMED.BO | 034940.KQ | BDH.BO | |
|---|---|---|---|---|---|---|
| Market cap | 5.50B | 2.52B | 30.95B | 9.36B | 9.98B | 2.45B |
| P/E (TTM) | — | 14.9 | 14.2 | 23.5 | — | 21.0 |
| Forward P/E | -147.4 | 10.4 | 12.4 | — | — | 59.2 |
| Price/book | 19.1 | 1.3 | 3.0 | 2.4 | — | 3.2 |
| Dividend yield | — | — | 4.86% | 0.50% | — | 1.17% |
| 1-year change | −41.12% | −13.17% | +20.69% | −15.42% | −69.57% | −1.43% |
| Today | +3.97% | +7.55% | +1.43% | +1.22% | 0.00% | −0.20% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 82W.F news ›HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
NEW YORK, Nov. 2, 2026 /PRNewswire/ -- 2, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both…
More from 3 other outlets
- TMX Newsfile HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline
- @PRNewswire HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - November 2, 2026 Deadline
- GlobeNewswire News Room HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
Hims & Hers Health, Inc. (NYSE:HIMS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Hims & Hers Health, Inc. Securities Lawsuit - Contact Portnoy Law Firm
Please visit our website for more information on how to participate in this class action. WHY PORTNOY LAW FIRM Lead Plaintiff Deadline: Investors who suffered losses on Hims & Hers Health, Inc. stock during the Class Period have until…
HIMS Deadline in 3 Days: Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP
Oct 30, 2026, 08:40 ET Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS: If you purchased or acquired HIMS securities and have lost money on your…
Teladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up
Teladoc posted falling revenue yet still managed to beat Wall Street on both sales and profit, sending shares surging. The real question is whether a surprising shift inside its BetterHelp unit can turn a struggling business into a growth…
What Should Hims & Hers Health, Inc. Investors Know After 14.73% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Oct 30, 2026, 13:10 ET Lawsuit alleges Hims & Hers Health, Inc. made misleading statements to investors from August 4, 2025 to July 29, 2026; lead plaintiff motions are due November 2, 2026 If you lost money on Hims & Hers Health, Inc.…
Financial Comparison: Hims & Hers Health (NYSE:HIMS) & Exagen (NASDAQ:XGN)
Posted by Defense World Staff on Oct 28th, 2026 Hims & Hers Health (NYSE:HIMS – Get Free Report) and Exagen (NASDAQ:XGN – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors... NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating…
Hims & Hers Health, Inc. (NYSE:HIMS) Stock Has Average Target Price of $32.43 According to Analysts
Posted by Tristan Rich on Oct 25th, 2026 Here are the key news stories impacting Hims & Hers Health this week: Hims & Hers Health, Inc is a direct-to-consumer health and wellness company that provides telehealth services through the Hims…
Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd
If you purchased or acquired Hims securities between August 4, 2025 and July 29, 2026 and would like to discuss your 20, 2026 (GLOBE NEWSWIRE) --WhatâÂÂs Happening:Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Kahn Swick & Foti, LLC Encourages Investors With Substantial Losses in Hims & Hers Health, Inc. (HIMS) to Join Class Action Before Deadline
Kahn Swick & Foti, LLC Encourages Investors With Substantial Loss The National Law Review Kahn Swick & Foti, LLC Encourages Investors With Substantial Losses in Hims & Hers Health, Inc. (HIMS) to Join Class Action Before Deadline NEW YORK…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com27
- prnewswire.com19
- newsfilecorp.com15
- natlawreview.com4
- markets.financialcontent.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 99 articles, not a forecast.